MeSH tree: C12.200.294.565
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models. The tool, tested on over ...
Jan 12, 2026
0
13
Eating some common food preservatives is linked to a slightly higher risk of eventually developing cancer and diabetes, according to two large French studies published Thursday.
Jan 11, 2026
0
59
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.
Jan 7, 2026
0
18
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after treatment, particularly ...
Dec 19, 2025
0
14
For anyone facing cancer, the treatment options can feel brutally familiar: surgery, radiotherapy, chemotherapy, or a combination of them all. But a new approach is beginning to offer something very different. By using nothing ...
Nov 28, 2025
0
22
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive surgical margins occur in 15–40% of prostate cancer cases, the risk of postoperative recurrence and ...
Nov 24, 2025
0
14
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.
Nov 20, 2025
0
19
Benign prostatic hyperplasia (BPH) is associated with elevated risks for depression and anxiety, with a causal link to depression supported by genetic evidence, according to a study published online Nov. 5 in the International ...
Nov 18, 2025
0
13
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ...
Nov 5, 2025
0
11
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, and the Fred Hutchinson ...
Nov 5, 2025
0
39
